, Volume 47, Issue 3, pp 479–482 | Cite as

Actinomyces spp. bloodstream and deep vein thrombus infections in people who inject drugs

  • Emma TippettEmail author
  • Nupur Goyal
  • Stephen Guy
  • Jenny Wong
Case Report



Actinomyces spp. cause several well-described syndromes including cervicofacial and pelvic infections. Actinomyces spp. infection as an opportunistic infection among people who inject drugs has rarely been described with few case reports published.

Methods and results

Here we describe four people who inject drugs admitted with Actinomyces spp. infections, all with an overlapping syndrome and who presented a challenge to both diagnose and to manage.


This case series highlights the potential to overlook Actinomyces spp. infection in people who inject drugs and aims to increase clinician awareness of diagnosis, empirical and directed treatment, and potential complications of this infection.


Actinomyces Actinomycosis Anaerobe Injecting drug use Intravenous drug use 



Deep vein thrombosis




People who inject drugs


Compliance with ethical standards

Conflict of interest

The authors have no conflict of interest to declare.


  1. 1.
    Wong VK, Turmezei TD, Weston VC. Actinomycosis. BMJ. 2011;343:d6099.CrossRefGoogle Scholar
  2. 2.
    Holm P. Studies on the aetiology of human actinomycosis. Acta Pathol Microbiol Scand Suppl. 1951;91:172–3.Google Scholar
  3. 3.
    Bonnefond S, Catroux M, Melenotte C, Karkowski L, Rolland L, Trouillier S, et al. Clinical features of actinomycosis: a retrospective, multicenter study of 28 cases of miscellaneous presentations. Medicine (Baltimore). 2016;95(24):e3923.CrossRefGoogle Scholar
  4. 4.
    Bing AU, Loh SF, Morris T, Hughes H, Dixon JM, Helgason KO. Actinomyces species isolated from breast infections. J Clin Microbiol. 2015;53 10:3247–55.CrossRefGoogle Scholar
  5. 5.
    Summanen PH, Talan DA, Strong C, McTeague M, Bennion R, Thompson JE Jr, et al. Bacteriology of skin and soft-tissue infections: comparison of infections in intravenous drug users and individuals with no history of intravenous drug use. Clin Infect Dis. 1995;20(Suppl 2):279–82.Google Scholar
  6. 6.
    Weiand D, Barlow G. The rising tide of bloodstream infections with Actinomyces species: bimicrobial infection with Actinomyces odontolyticus and Escherichia coli in an intravenous drug user. Oxf Med Case Rep. 2014;2014 9:156–8.CrossRefGoogle Scholar
  7. 7.
    Hoye S, Tolan D, Brownjohn A. Septic pulmonary embolism in an intravenous drug user. Acute Med. 2010;9(1):15–9.Google Scholar
  8. 8.
    Mehrzad R, Sublette M, Barza M. Polymicrobial endocarditis in intravenous heroin and fentanyl abuse. J Clin Diagn Res. 2013;7 12:2981–5.Google Scholar
  9. 9.
    Oh S, Havlen PR, Hussain N. A case of polymicrobial endocarditis due to anaerobic organisms in an injection drug user. J Gen Intern Med. 2005;20 10:958-.CrossRefGoogle Scholar
  10. 10.
    Westling K, Lidman C, Thalme A. Tricuspid valve endocarditis caused by a new species of actinomyces: Actinomyces funkei. Scand J Infect Dis. 2002;34(3):206–7.CrossRefGoogle Scholar
  11. 11.
    Sofianou D, Avgoustinakis E, Dilopoulou A, Pournaras S, Tsirakidis G, Tsakris A. Soft-tissue abscess involving Actinomyces odontolyticus and two Prevotella species in an intravenous drug abuser. Comp Immunol Microbiol Infect Dis. 2004;27(2):75–9.CrossRefGoogle Scholar
  12. 12.
    Webb D, Thadepalli H. Skin and soft tissue polymicrobial infections from intravenous abuse of drugs. West J Med. 1979;130 3:200–4.Google Scholar
  13. 13.
    Zaman R, Abbas M, Burd E. Late prosthetic hip joint infection with Actinomyces israelii in an intravenous drug user: case report and literature review. J Clin Microbiol. 2002;40 11:4391–2.CrossRefGoogle Scholar
  14. 14.
    Bennhoff DF. Actinomycosis: diagnostic and therapeutic considerations and a review of 32 cases. Laryngoscope. 1984;94(9):1198–217.CrossRefGoogle Scholar
  15. 15.
    Clarridge JE III, Zhang Q. Genotypic diversity of clinical Actinomyces species: phenotype, source, and disease correlation among genospecies. J Clin Microbiol. 2002;40(9):3442–8.CrossRefGoogle Scholar
  16. 16.
    Lerner PI. The lumpy jaw. Cervicofacial actinomycosis. Infect Dis Clin North Am. 1988;2(1):203–20.Google Scholar
  17. 17.
    Smith AJ, Hall V, Thakker B, Gemmell CG. Antimicrobial susceptibility testing of Actinomyces species with 12 antimicrobial agents. J Antimicrob Chemother. 2005;56(2):407–9.CrossRefGoogle Scholar
  18. 18.
    Macfarlane DJ, Tucker LG, Kemp RJ. Treatment of recalcitrant actinomycosis with ciprofloxacin. J Infect. 1993;27(2):177–80.CrossRefGoogle Scholar
  19. 19.
    Prashant N, Azuhairy A. Actinomycosis of distal phalanx twenty years after flap reconstruction of index finger: a case report. Malays Orthop J. 2018;12(1):48–50.CrossRefGoogle Scholar
  20. 20.
    Atad J, Hallak M, Sharon A, Kitzes R, Kelner Y, Abramovici H. Pelvic actinomycosis. Is long-term antibiotic therapy necessary? J Reprod Med. 1999;44(11):939–44.Google Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Western HealthMelbourneAustralia
  2. 2.Eastern HealthMelbourneAustralia
  3. 3.Department of Medicine, Melbourne Medical School, Western PrecinctThe University of MelbourneSt. AlbansAustralia
  4. 4.Dorevitch PathologyMelbourneAustralia

Personalised recommendations